Loading page…
Zealand Pharma A/S 2016 Annual Report
Company: Zealand Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2016
Type: Annual Report
Pages: 84
The report describes Zealand's 2016 transition toward a more sustainable biotech company, highlighted by U.S. approvals and launches of Adlyxin and Soliqua. Revenue reached DKK 234.8 million, driven mainly by milestone payments and royalties. The CSR agenda covered employee well-being, diversity, ethics, animal welfare and environmental sustainability.
No standards or assurance data is available for this report.
Indicators available in this report:
No materiality data is available for this report.